BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hong Kong

Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US

Fosun Pharma will have the right to commercialise serplulimab upon approval in the US, and Henlius will retain responsibility for development, manufacturin...

January 09, 2023 | News

Prenetics Acquires ACT Genomics

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genom...

December 16, 2022 | News

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development

AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide...

November 25, 2022 | News

Gilead Sciences Celebrates Top Ranking By Hepatitis and Asian Patient Groups

Gilead also ranks first among peers in Asia by patient groups in this region -- Gilead Sciences, Inc. ranks first among peers for over...

September 15, 2022 | News

The first AXA Medical Centre officially unveils

AXA and EC Healthcare today (8 September) held the "AXA Medical Centre Unveiling and AXA Hong Kong and EC Healthcare MOU Signing Ceremony", pledging to wor...

September 13, 2022 | News

Intellect engages with MSIG Hong Kong to provide holistic mental health support to their policyholders

The market-leading insurance company saw the need for a personalised and comprehensive platform that would address the issue ...

July 05, 2022 | Opinion

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

“This collaboration with Twist moves us closer to our vision of becoming a fully global healthcare company while also continuing to drive novel thera...

July 01, 2022 | News

Antengene Announces Clinical Trial Collaboration with BeiGene

Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor Antengene Corporation Limited ("...

June 27, 2022 | News

BGI Genomics supports post-pandemic recovery in Hong Kong

As of May 31, 2022, BGI Genomics (300676.SZ) conducted approximately 446,000 and 5.7 million COVID-19 tests at the airport and Com...

June 15, 2022 | News

Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong

Test sensitivity of 96% in colorectal cancer and 64% in advanced adenoma detection in clinical studies- ColoClear is the only cancer screening test ap...

June 09, 2022 | News

Birmingham Biotech and Tanner Pharma Group enter distribution partnership for innovative nasal spray in Latin America

TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner for the commercialization of their products in challenging...

June 01, 2022 | News

New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer

New Horizon Health and Prenetics will jointly promote ColoClear in Hong Kong, Macau and Taiwan, with additional options to expand the p...

May 24, 2022 | News

Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong

Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 9) released on March 15, 2022 by the National Health Commiss...

April 04, 2022 | News

iMeddy provides free video medical consultation to COVID-19 patients

The service is being carried out in two phases. The first phase, which is now complete, targeted low-income families, while the upcoming second phase will ...

March 25, 2022 | News

Stay Connected